Diagnostic Value of Arterial Blood Gas Analysis in Prehospital Patients

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

In the anesthesiologist-manned mobile emergency car unit an analyzing device for blood gas testing is present since 2014. This study will determine if a prehospital arterial blood gas helps the doctor to make more precise diagnosis prehospitally. Furthermore it will be determined if the doctors find this device helpful in assessing and treating patients with affected consciousness.

See also
	Status	Clinical Trial	Phase
	Completed	`NCT03727464` - Memory Priming in General Anesthesia	N/A

NCT number	NCT03006692
Study type	Observational
Source	Odense University Hospital
Contact
Status	Completed
Phase
Start date	June 2016
Completion date	April 1, 2018

Diagnostic Value of Arterial Blood Gas Analysis in Prehospital Patients — ABL

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms